Camden National (CAC) Q1 2026 earnings review
Core Operations Stabilize Post-Merger, But Top-Line Growth Pauses
A year after digesting Northway Financial, Camden National has found its baseline. First-quarter 2026 Net Income landed at $21.9 million ($1.29 EPS), representing a slight deceleration from Q4 2025's $22.6 million ($1.33 EPS), but a massive 199% improvement YoY against the noisy, acquisition-heavy Q1 2025. The quarter was defined by excellent expense control and pristine credit quality, offset by a sequential decline in both Net Interest Income (-3%) and Non-Interest Income (-15%). While reported Net Interest Margin compressed 5 basis points to 3.24% due to fading purchase accounting accretion, Core NIM remained perfectly stable at 2.92%. Management executed well on the balance sheet, utilizing unexpected deposit growth to aggressively pay down more expensive short-term borrowings.
🐂 Bull Case
Management previously guided Q1 2026 operating expenses to $36-$37 million. Actual non-interest expense came in at $35.7 million (down 3% sequentially), proving the Northway integration cost synergies are sticky and sustainable.
The Q2 2025 syndicated loan scare is firmly in the rearview mirror. Provision expense plummeted to just $553K, and annualized net charge-offs are a near-zero 0.04%. The allowance ratio sits at a comfortable 0.92%.
🐻 Bear Case
Both sides of the revenue equation decelerated sequentially. Net Interest Income fell 3% as average interest-earning assets declined 1%, and non-interest income dropped 15% due to timing and seasonality.
Total loans ended at $4.96 billion, essentially flat compared to Q4 2025. While typical for Q1 seasonality, it challenges the 'mid-single digit' full-year 2026 growth target laid out in the prior quarter.
⚖️ Verdict: ⚪
Neutral. The company is managing what it can control—expenses, credit, and deposit mix—exceptionally well. However, to justify further multiple expansion, Camden needs to reignite organic loan growth and offset the fading benefits of purchase accounting accretion.
Key Themes
Deposit Base Defies Flat Guidance, Replacing Expensive Funding
Deposits grew 1% sequentially to $5.6 billion. This is notable because management guided on the Q4 2025 call for Q1 deposits to be 'relatively flat' due to seasonal winter outflows. The growth, driven by a high-yield savings product and new business onboarding, allowed Camden to slash short-term borrowings by 12% ($68.3 million) in a single quarter, optimizing the liability side of the balance sheet.
Reported NIM Trend Reversing
After four consecutive quarters of expansion (peaking at 3.29% in 25Q4), reported Net Interest Margin compressed by 5 basis points to 3.24%. Management attributed this to $956,000 less in fair value mark accretion income. While Core NIM (which strips out this accretion) was perfectly stable at 2.92%, the fading artificial boost from the Northway acquisition means NII growth must now rely entirely on organic volume, which was negative this quarter.
Non-Interest Income Deceleration
Fee income reversed its positive trajectory, falling 15% sequentially to $12.0 million. The drop was driven by lower debit card income (down 27% QoQ to $3.4M) due to seasonality and Visa incentive timing, as well as lower customer loan swap income. Management expects a normalization in Q2, aligning with their prior full-year baseline guidance of a $12M-$13M quarterly run rate.
Credit Normalization Confirmed
Asset quality is stable. The massive provision spikes seen in early 2025 (Q1: $9.4M for Northway, Q2: $6.9M for a syndicated loan bankruptcy) have fully normalized. Q1 2026 provision was just $553K. Non-performing assets remain benign at 0.16% of total assets, and the ACL covers non-performing loans by a robust 4.2 times.
Capital Return Re-Initiation
After pausing to rebuild capital following the January 2025 Northway acquisition, Camden repurchased 33,131 shares in Q1 at a weighted-average price of $44.85. While small compared to the 850,000 share authorization announced in Jan 2026, it signals management's returning confidence in their capital stack (CET1 up to 12.01%).
Other KPIs
Stable/Decelerating. Down 3% linked-quarter from $36.9M. This beat management's explicit Q1 guide of $36-$37M. The efficiency ratio (Non-GAAP) ticked up slightly to 53.21% (from 51.69%), but this was entirely due to the denominator (revenue) shrinking rather than expense bloat.
Accelerating vs late 2025, but lower than mid-2025 peaks. Entered Q2 2026 with $128.3 million, up from $110.3 million entering Q1 2026, but trailing the $150 million pipeline touted in Q2 2025. This metric needs to convert to balance sheet growth to achieve their stated full-year targets.
Guidance
Management expects fee income to 'normalize in the second quarter of 2026' after the Q1 dip. Based on previous call summaries, their established baseline is a $12M to $13M quarterly run rate.
Management previously guided to mid-single-digit loan growth for 2026. With Q1 coming in flat (0% growth), this implies accelerating production will be required in Q2-Q4 to hit the annual target.
Key Questions
Loan Growth Catch-Up
With Q1 loan balances coming in flat, what specific catalysts in the $128.3M pipeline give you confidence in hitting the previously stated 'mid-single digit' growth target for 2026?
Core NIM Trajectory
Core NIM has stabilized at 2.92%. Given the 12% reduction in short-term borrowings this quarter and your liability-sensitive positioning, should we expect Core NIM to resume its expansion trend in Q2?
Pace of Buybacks
You executed roughly 33,000 shares of repurchases this quarter against an 850,000 share authorization. Was this pace dictated by blackout periods, or does it reflect a preference to hold capital for organic growth opportunities in the newly acquired New Hampshire markets?
Commercial Real Estate
Commercial Real Estate balances remained flat sequentially at $2.19B. Are you actively tapping the brakes on CRE originations given macro concerns, or is this a function of elevated paydowns?